AstraZeneca (AZN) Opens Lower After Reports Q4 Results
AstraZeneca (NYSE: AZN) reported Q4 EPS of $1.56, versus ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
